Atopic dermatitis: therapeutic challenge in an infant with dystrophic epidermolysis bullosa

V Sibaud1, S Roul, C Leaute-Labreze

  • 1Paediatric Dermatology Unit, Hôpital Pellegrin, Place Amelie Raba-Léon, 33076 Bordeaux cedex 9, France.

Insights

Dystrophic epidermolysis bullosa (EB) can worsen with atopic dermatitis (AD). Managing AD improved skin symptoms in an infant, highlighting the importance of treating coexisting inflammatory skin disorders in EB patients.

Area of Science:

  • Dermatology
  • Genetics
  • Pediatrics

Background:

  • Inherited epidermolysis bullosa (EB) is a group of rare genetic disorders characterized by fragile skin that blisters and tears easily.
  • The severity of EB varies widely, from mild blistering to severe, life-threatening conditions.
  • Atopic dermatitis (AD) is a common inflammatory skin condition causing itching and skin barrier dysfunction.

Observation:

  • A case report details an infant diagnosed with dystrophic epidermolysis bullosa (DEB).
  • The infant also presented with atopic dermatitis (AD), which significantly exacerbated the EB symptoms.
  • Intense scratching associated with AD led to increased blistering and milia formation in the DEB patient.

Findings:

  • Concomitant atopic dermatitis (AD) worsened the clinical presentation of inherited epidermolysis bullosa (EB).
  • The inflammatory nature of AD and associated scratching triggered new blisters and milia in the infant.
  • Targeted management of atopic dermatitis (AD) resulted in substantial improvement of the cutaneous manifestations of epidermolysis bullosa (EB).

Implications:

  • Coexisting inflammatory skin disorders, such as atopic dermatitis (AD), can significantly impact the prognosis of inherited epidermolysis bullosa (EB).
  • Thorough documentation and prompt treatment of inflammatory skin conditions are crucial for managing patients with EB.
  • Addressing secondary conditions like AD can lead to better outcomes and improved quality of life for individuals with EB.

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...